[
    [
        {
            "time": "",
            "original_text": "【民生医药|跟踪点评】泰格医药：与日本CRO合作深化，关注国际化拓展进度",
            "features": {
                "keywords": [
                    "泰格医药",
                    "日本CRO",
                    "合作深化",
                    "国际化拓展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【民生医药|跟踪点评】泰格医药：与日本CRO合作深化，关注国际化拓展进度",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "泰格医药现1笔大宗交易 共成交259.05万元",
            "features": {
                "keywords": [
                    "泰格医药",
                    "大宗交易",
                    "成交金额"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泰格医药现1笔大宗交易 共成交259.05万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "泰格医药：拟收购日本EPS部分股权 拓展亚太区业务",
            "features": {
                "keywords": [
                    "泰格医药",
                    "收购",
                    "日本EPS",
                    "亚太区业务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "泰格医药：拟收购日本EPS部分股权 拓展亚太区业务",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【医药】300347*泰格医药:Q3单季扣非净利翻倍，业绩持续高增长超预期*买入",
            "features": {
                "keywords": [
                    "泰格医药",
                    "Q3",
                    "扣非净利翻倍",
                    "业绩高增长",
                    "买入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】300347*泰格医药:Q3单季扣非净利翻倍，业绩持续高增长超预期*买入",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【川财研究所*常规报告】泰格医药（300347）：Q3收入端增速略有放缓，利润持续兑现 盈利能力下降",
            "features": {
                "keywords": [
                    "泰格医药",
                    "Q3",
                    "收入端增速放缓",
                    "利润持续兑现",
                    "盈利能力下降"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【川财研究所*常规报告】泰格医药（300347）：Q3收入端增速略有放缓，利润持续兑现 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "格力“招亲”选定高瓴 就等董小姐说“我愿意”",
            "features": {
                "keywords": [
                    "格力",
                    "招亲",
                    "高瓴",
                    "董明珠"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "家电"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "格力“招亲”选定高瓴 就等董小姐说“我愿意”",
                "Correlation": 1,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "格力混改尘埃落定! 高瓴资本张磊入驻董明珠仍居C位!",
            "features": {
                "keywords": [
                    "格力",
                    "混改",
                    "高瓴资本",
                    "张磊",
                    "董明珠"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "家电"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "格力混改尘埃落定! 高瓴资本张磊入驻董明珠仍居C位!",
                "Correlation": 1,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]